|
⚲
|
| Keyboard |
| Aisling Capital Partners IV LP | |
|---|---|
| Firm | Aisling Capital Management LP |
| Address | 888 Seventh Avenue, 12th Floor New York, NY 10106 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aisling Capital Management LP | |||||
| Aisling Capital IV LP | 021-248934 | Executive Officer | 143.1 M of 400.0 M |
506.4 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Elevation Oncology Inc ELEV
Stock Option (Right to Buy) · derivative
|
2023-06-16 | Grant | 31,238 | $0.00 | |
|
Elevation Oncology Inc ELEV
Stock Option (Right to Buy) · derivative
|
2022-06-17 | Grant | 15,619 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2021-06-29 | Conversion | 458,360 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2021-06-29 | Conversion | 1,893,232 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2021-06-29 | Buy | 187,500 | $16.00 | 3,000,000 |
|
Elevation Oncology Inc ELEV
Series B Preferred Stock · derivative
|
2021-06-29 | Conversion | 1,936,834 | $0.00 | |
|
Elevation Oncology Inc ELEV
Series A Preferred Stock · derivative
|
2021-06-29 | Conversion | 8,000,000 | $0.00 | |
|
Elevation Oncology Inc ELEV
Director Stock Option · derivative
|
2021-06-24 | Grant | 31,238 | $0.00 | |
|
Zosano Pharma Corp ZSAN
Common Stock, par value of $0.0001
|
2019-12-02 | Grant | 689,655 | $1.45 | 1,000,000 |
|
Sunesis Pharmaceuticals Inc SNSS
Common Stock
|
2019-07-15 | Buy | 2,500,000 | $0.60 | 1,500,000 |
|
Zosano Pharma Corp ZSAN
Common Stock, par value of $0.0001
|
2019-04-11 | Grant | 428,571 | $3.50 | 1,499,998 |